Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on November 12, 2026

BioWraptor Raises $1.5 Million Pre-Seed Round to Advance Room-Temperature Stabilization of Biologics
Broadway, TV, and Film Performers Join Drew Lachey at All-Star Benefit for Hospitalized Kids at The Green Room 42
Tribeca Dental Studio Announces CPAP-Alternative Sleep Apnea Treatment Program in Tribeca
All-on-4, Sinus Lift and Custom Bone Grafting in Tribeca: Rebuilding the Bone Implants Need
Lifebox Names Natalie Meyers Global CEO to Advance Safe Surgery Worldwide
Minch Global Trade Inc. Earns Silver at the 2026 MUSE Design Awards for B Beworths Packaging
American Friends of NATAL Holds NYC Gala for Israel's Mental Health Crisis, Featuring Returned Hostage Alon Ohel
Rochester Arthritis & Joint Pain Center Highlights New Non-Surgical Solutions for Knee, Hip, and Shoulder Pain
NPO: World Kindness Day Not Enough, Adopt Planned Acts of Kindness and HEART Initiatives for Lasting Quality of Life
Our God of Second Chances Traces Love Rekindled Across Decades and Faith Tested by Illness
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer’s Disease
Windward Bio Announces Pricing of Initial Public Offering
Vivan Therapeutics set to Begin TuMatch™ Clinical Registration Study at Burjeel Cancer Institute, Abu Dhabi
VitalHub Reports Third Quarter 2026 Results
POTS Phase 2 Trial Shows Baloncibart, a First-in-Class NPR1 Blocking Antibody, Reduced Orthostatic Heart Rate and Improved Orthostatic Symptoms
Longeveron Announces 2026 Third Quarter Financial Results and Provides Business Update
Eledon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Business Highlights
YD Bio Announces FDA Grant of INTERACT Meeting Request for YDB-LMSCEV-001, an Investigational Extracellular Vesicle Candidate for Dry Eye Disease
Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights
New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health & Wellness Today New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.